A recent subset of monocytes, CD14− and CD16− monocytes, characterized by the absence of their surface markers CD14 and CD16, is gaining increased attention for their role in neuroinflammatory states associated with chronic conditions such as epilepsy and neurodegenerative diseases. This evidence concerns the gene CD14 and epilepsy.